BX Swiss TOP 30 CHF
1.263,02
PKT
-5,91
PKT
-0,47
%
Werbung
Analysen zu BX Swiss TOP 30 CHF-Werten
Datum | Rating | Analyst | |
---|---|---|---|
05.04.18 | Swiss Re overweight | JP Morgan Chase & Co. | |
05.04.18 | Swiss Re buy | Deutsche Bank AG | |
05.04.18 | UBS Hold | Deutsche Bank AG | |
05.04.18 | UBS buy | Deutsche Bank AG | |
05.04.18 | Nestlé buy | Goldman Sachs Group Inc. | |
04.04.18 | Swiss Re Sell | UBS AG | |
04.04.18 | Swiss Re buy | Baader Bank | |
04.04.18 | Nestlé Outperform | RBC Capital Markets | |
03.04.18 | Swiss Re overweight | JP Morgan Chase & Co. | |
03.04.18 | Roche overweight | JP Morgan Chase & Co. | |
03.04.18 | ABB (Asea Brown Boveri) Conviction Buy List | Goldman Sachs Group Inc. | |
03.04.18 | Nestlé Neutral | UBS AG | |
03.04.18 | UBS buy | UBS AG | |
29.03.18 | Zurich Insurance Neutral | UBS AG | |
29.03.18 | Swiss Re Neutral | Goldman Sachs Group Inc. | |
29.03.18 | Swiss Re overweight | Barclays Capital | |
29.03.18 | Swiss Re Sector Perform | RBC Capital Markets | |
29.03.18 | Roche Hold | Deutsche Bank AG | |
28.03.18 | ABB (Asea Brown Boveri) Neutral | JP Morgan Chase & Co. | |
28.03.18 | Novartis buy | Oddo Seydler Bank AG | |
28.03.18 | Zurich Insurance Equal weight | Barclays Capital | |
28.03.18 | Novartis Hold | Deutsche Bank AG | |
27.03.18 | Novartis buy | S&P Capital IQ | |
27.03.18 | Novartis buy | Baader Bank | |
27.03.18 | Novartis Neutral | UBS AG | |
27.03.18 | Givaudan Neutral | Goldman Sachs Group Inc. | |
27.03.18 | UBS Outperform | Credit Suisse Group | |
27.03.18 | Givaudan Hold | Kepler Cheuvreux | |
27.03.18 | Roche Conviction Buy List | Goldman Sachs Group Inc. | |
27.03.18 | Roche overweight | JP Morgan Chase & Co. | |
27.03.18 | Nestlé overweight | JP Morgan Chase & Co. | |
27.03.18 | Givaudan overweight | JP Morgan Chase & Co. | |
27.03.18 | Roche Underweight | Morgan Stanley | |
27.03.18 | Givaudan Hold | Deutsche Bank AG | |
26.03.18 | Nestlé Outperform | RBC Capital Markets | |
26.03.18 | Givaudan Neutral | Goldman Sachs Group Inc. | |
23.03.18 | UBS overweight | Morgan Stanley | |
23.03.18 | Roche buy | Jefferies & Company Inc. | |
23.03.18 | Swiss Re buy | Deutsche Bank AG | |
21.03.18 | Roche Hold | Deutsche Bank AG |